✨ Free AI Report
Galderma Group AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Galderma Group AG
Company Research

Galderma Group AG: Business Overview, Financials & Competitive Analysis

Galderma is a pure-play, science-based dermatology company delivering a comprehensive portfolio spanning injectable aesthetics, dermatological skincare, and therapeutic dermatology. With over 90% of sales from self-ca...

Analyst-debate audio for Galderma Group AG

AskCyborg analysts argue the bull and bear cases for Galderma Group AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
8/ 10Strong

Cyborg Score thesis

Premium dermatology pure-play capitalizing on growing consumer demand for skin health solutions with leading branded portfolio...

Read the full analyst-debate transcript →
Industry Specialty Pharmaceuticals & Dermatology
5 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Galderma Group AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Galderma Group AG Overview

Pro stress-test →

Galderma is a pure-play, science-based dermatology company delivering a comprehensive portfolio spanning injectable aesthetics, dermatological skincare, and therapeutic dermatology. With over 90% of sales from self-care segments paid out-of-pocket by consumers, the company is positioned to benefit from growing consumer focus on skin health and appearance globally.

Strategic Profile

Pro stress-test →

Galderma leverages a specialized omnichannel go-to-market strategy supported by a dedicated salesforce of over 1,900 professionals reaching 200,000+ healthcare providers. The company's leadership position is reinforced through flagship brands including Restylane, Dysport/Azzalure, Sculptra in aesthetics and Cetaphil, Soolantra, Epiduo in dermatological care, with a robust innovation pipeline driving accelerated growth potential.

Competitive Landscape

Pro stress-test →

Galderma competes in the dermatology and aesthetic markets against diversified healthcare companies and specialized dermatology players. Key competitors include Almirall (Spain-based dermatology focus), GSK (diversified pharma with dermatology portfolio), and Pierre Fabre, alongside aesthetic innovators. Galderma's pure-play focus and direct-to-consumer aesthetic segment differentiate it from broader pharmaceutical players.

Industry Context

Galderma Group AG operates in Specialty Pharmaceuticals & Dermatology.

Key facts

Founded: 1981 · Headquarters: Zug, Switzerland · Employees: 4,600 · Revenue: $4.69B · Market cap: $44.2B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Galderma Group AG.

  • Pure-play dermatology company with 90%+ of sales from self-care segment driven by consumer out-of-pocket spending
  • Recently IPO'd on SIX Swiss Exchange (March 2024) following successful $2.4B+ offering; stock appreciated significantly since listing
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • December 2024FDA approval of Nemluvio for adult atopic dermatitis patients
  • August 2024FDA approval of Nemluvio for prurigo nodolaris in adult patients
  • +1 moreTrack every material event for Galderma Group AG as it happens. Explore monitoring →
Get alerted when Galderma Group AG has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

RestylaneLeading dermal filler for aesthetic rejuvenation→DysportNeuromodulator for facial aesthetics→BotoxBotulinum toxin for aesthetic and therapeutic uses→JuvedermHyaluronic acid dermal filler→VitraseHyaluronidase enzyme for aesthetic procedures→

Compare Galderma Group AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Galderma Group AG operates in Specialty Pharmaceuticals & Dermatology. See how the rest of the sector scores on the Cyborg framework.

Browse Specialty Pharmaceuticals & Dermatology research →
NEW · MCP server

Ask your AI assistant about Galderma Group AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Galderma Group AG and its top competitor on Cyborg Score”
“What did Galderma Group AG do this quarter?”
“Is Galderma Group AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Galderma Group AG do?+
Galderma is a pure-play, science-based dermatology company delivering a comprehensive portfolio spanning injectable aesthetics, dermatological skincare, and therapeutic dermatology. With over 90% of sales from self-ca...
What is Galderma Group AG's Cyborg Score?+
Galderma Group AG has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Galderma Group AG's main competitors?+
Named competitors include Restylane, Dysport, Botox, Juvederm. The full competitive landscape is in the AskCyborg report.
How can I get the full Galderma Group AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Galderma Group AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Galderma Group AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.